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Abstract Q1- and Q2-zeathionins (Q1-Z and Q2-Z) are members
of a family of small and basic peptides involved in plant
protection. These plant defensins exhibit remarkable structural
similarity to scorpion neurotoxins and insect defensins. In the
present report, we used the whole-cell patch clamp technique to
investigate the inhibition of the sodium current (INa) by Q1-Z and
Q2-Z in the GH3 cell line. Both Q1-Z and Q2-Z rapidly and
reversibly inhibited INa without changing the kinetics or voltage
dependence of activation or inactivation. To our knowledge, this
is the first example of a plant protein that inhibits the sodium
channel. From structural comparisons with the W-conotoxins, a
family of peptides that block the sodium channel, we detected
some similar features that could provide the basis of inhibition of
sodium channels by Q-zeathionins.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Plants are continuously exposed to many pests and patho-
gens and in self-defense they produce many compounds with
toxic properties. One group of proteins probably involved in
plant resistance against fungal and bacterial pathogens is the
Q-thionin family [1]. These proteins form a group of small
(5 kDa), highly basic and disul¢de-rich polypeptides isolated
from several monocots [2^6]. We have recently reported the
complete amino acid sequences of two Q-thionins from maize
(Zea mays L.) called Q1- and Q2-zeathionins (Q1-Z and Q2-Z)
[7]. Q1-Z and Q2-Z are clearly homologous with 31% identity in
their amino acid sequences and four disul¢de bridges.
The Q-zeathionins exhibit a high degree of homology with
other Q-thionins whose three-dimensional structures have been
established by 2D NMR and resemble neurotoxins found in
scorpion venom which bind with high a⁄nity and speci¢city
to voltage-gated ion channels [8,9]. Among other conserved
characteristics, they present a common structural motif
formed by an K-helix connected to an extended structure by
disul¢de bridges, originally named CSH (cysteine-stabilized K-
helix) motif [10], but currently de¢ned as CSKL (cysteine-sta-
bilized K-helix L-sheet) motif [11]. Another group of toxins
that act on ion channels are the W-conotoxins, a class of three
related 22-residue peptide amides, each with three disul¢de
bonds, isolated from the venom of the piscivorous sea snail,
Conus geographus L. [12^15]. These peptides speci¢cally block
muscle-type sodium channels [16]. Structural similarities be-
tween Q-thionins and W-conotoxins suggest that these peptides
may share a similar mechanism of action.
In the present study, we employ the whole-cell patch clamp
technique [17] to investigate the e¡ect of Q1- and Q2-zeathio-
nins on voltage-gated ion channels in the GH3 cell line.
2. Materials and methods
2.1. Materials
Q1-Z and Q2-Z were puri¢ed from maize (Zea mays L.) seeds by
saline extraction, ammonium sulfate precipitation, pseudo-a⁄nity and
RP-HPLC chromatographies as previously described [7]. Cell culture
sera and antibiotics were from Gibco BRL. Other chemicals were
from Sigma, unless otherwise speci¢ed.
2.2. Cell culture
GH3 cells were purchased from American Type Culture Collection
(Rockville, MD). The cells were kept in Ham’s F-10 medium supple-
mented with 15% horse serum, 2.5% fetal bovine serum, 50 U/ml
penicillin and 50 Wg/ml streptomycin. Cells were fed three times per
week and were maintained in a 5% CO2 atmosphere at 37‡C. For
experiments, cells were plated onto sterile plastic dishes and used
1^10 days later.
2.3. Electrophysiology
The whole-cell patch clamp technique [17] was employed at room
temperature (23^25‡C) to measure ionic currents. Pipettes were pulled
from glass capillaries and had a resistance of 1^3 M6 when ¢lled with
pipette solution. We measured currents in two sets of solutions, one
designed to isolate the Na current and the other to measure total
cellular currents, as described below.
To isolate the Na current, we used a reversed sodium gradient
[18]. Extracellular solution contained (in mM): choline chloride 150,
CaCl2 2, CdCl2 0.2, HEPES 10 pH 7.3 (adjusted with CsOH). Pipette
solution contained (in mM): NaF 100, NaCl 30, EGTA 10, HEPES 5
pH 7.3 (adjusted with CsOH). We used positive pressure in the pipette
during the approach to the cell, a common practice used to keep the
pipette tip clean of debris. A note of caution is warranted, however,
when using this combination of solutions. We often experienced salt
precipitation at the pipette tip, which we assume is CaF2 (solubility at
18‡C is about 0.2 mM), formed when the pipette solution mixed with
the extracellular solution. This problem was alleviated by reducing the
amount of positive pressure in the pipette.
To measure total cellular currents, we used solutions designed to
mimic physiologic intra- and extracellular ionic concentrations. Ex-
tracellular solution contained (in mM): NaCl 150, KCl 5.4, CaCl2 1.8,
MgCl2 0.5, glucose 10, HEPES 5 pH 7.4 (adjusted with NaOH).
Pipette solution contained (in mM): KCl 140, NaCl 10, EGTA 5,
HEPES 10 pH 7.4 (adjusted with KOH).
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The patch clamp ampli¢ers used were either an Axopatch 200B
with a Digidata 1200 A/D converter controlled by pClamp 6.01 soft-
ware (Axon Instruments) or an EPC-9 with Pulse software (HEKA).
Capacitive currents were electronically compensated and a P/4 proto-
col [19] was used for linear leak and capacitance subtraction. Na
currents were low-pass ¢ltered at 4 kHz and sampled at 20 kHz or
low-pass ¢ltered at 17 kHz and sampled at 50 kHz. Total cellular
currents (used to examine K currents) were low-pass ¢ltered at
2 kHz, then sampled at 5 kHz. The bandwidths are given in the ¢gure
legends. Series resistance compensation was used as necessary to keep
the error in membrane potential to below 2 mV.
Cells were held at a potential of 370 or 380 mV between voltage
pulses. Voltage pulse protocols are given in the text and ¢gure
legends.
Perfusion was accomplished using a micropipette (inner diameter
V500 Wm) positioned within 100 Wm of the cell under study. The
solution was gravity fed at V0.1 ml/min, and a solenoid valve al-
lowed the operator to choose between two solutions with a dead time
of 6 10 s. Cells under study were perfused continuously after whole-
cell patch clamp was achieved until currents had stabilized (usually
V5 min), at which point experiments were started.
Statistical values are given as means þ 95% con¢dence limits.
3. Results and discussion
The experiment of Fig. 1 shows the e¡ect of Q1-Z (100 WM)
and Q2-Z (50 WM) on positive sodium currents, elicited by
stepping the membrane potential from 3100 mV to +50 mV
in the presence of a reversed sodium gradient [18] (see Section
2). Inhibition of INa was rapid, reversible and repeatable. The
large graphs (A and D) show the time course of INa during
two cycles of application and washout of Q-zeathionin. The
cell under study was perfused continuously and INa sampled
every 1.4 s. At the times indicated by the bars, the toxin was
included in the perfusing solution. Representative currents are
shown (B and E) from di¡erent regions of the time course
curve as indicated by the numbers. Q1-Z and Q2-Z did not
a¡ect the kinetics of activation or inactivation of INa because
normalized currents before, during and after treatment had
essentially the same time course, as shown in parts C and F.
A dose-response curve for inhibition of INa by Q1-Z was
constructed. At concentrations of 400 WM or greater, Q1-Z
abolished INa. At four lower concentrations, inhibition of
INa by Q1-Z was dose-dependent (Fig. 2). Fitting a ¢rst-order
dose-response curve to the data on Q1-Z gave an IC50 of 62
WM. At a concentration of 50 WM, Q2-Z inhibited 60 þ 18% of
INa (n = 3 cells). Assuming ¢rst-order binding, this indicates
that the IC50 of Q2-Z is V33 WM.
To determine if Q1-Z inhibits the Na current by changing
the voltage dependence of activation or inactivation, the cur-
rent^voltage (I^V) relationship, and the voltage dependence of
steady-state inactivation were measured before and during
application of 50 WM Q1-Z, a concentration that inhibited
INa by 25.0 þ 2.6%. INa was measured as the peak inward
current during voltage steps to test potentials ranging from
360 mV to +70 mV in increments of 10 mV (Fig. 3). The
parameters of voltage dependence of activation and the rever-
sal potential were obtained by ¢tting a Boltzmann activation/
Ohm’s law equation (given in the ¢gure legend) to the peak
current at each test potential. Activation and reversal of INa
were not signi¢cantly modi¢ed by Q1-Z (curve-¢tting parame-
ters given in the ¢gure legend).
To measure the e¡ect of Q1-Z on the voltage dependence of
steady-state inactivation, cells were held at pre-pulse voltages
ranging from 3100 mV to 330 mV, then stepped to 0 mV for
50 ms to elicit currents (Fig. 4). The peak inward current was
plotted versus the test potential, and a Boltzmann relationship
was ¢t to the data to determine the potential at which INa is
half-inactivated (V0:5) and the steepness factor (K). V0:5 was
359.0 þ 8.2 mV in control solution and 365.0 þ 8.8 mV after
application of Q1-Z (n = 4). Thus, due to cell-to-cell variation,
there was no statistically signi¢cant shift in the average value
of V0:5 among cells. However, the average shift of V0:5, calcu-
lated by subtracting the value of V0:5 after application of Q1-Z
from the value obtained from the same cell in control solu-
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Fig. 1. Inhibition of INa by Q-zeathionins. Whole-cell patch clamp
was used with reversed sodium gradient solutions (see Section 2) to
measure INa. A: Time course of inhibition and recovery. INa was
measured at 1.4 s intervals by hyperpolarizing the cell to 3100 mV
for 200 ms to remove fast inactivation followed by a 50 ms step to
+50 mV. Cells were continuously perfused with control extracellular
solution. At the times indicated by the bars, 100 WM Q1-Z was
added to the perfusing solution. B: Representative currents from
the regions indicated by the numbers (1^6). C: Normalized currents.
D^F: Same as A^C except with 50 WM Q2-Z. Currents were ¢ltered
at 17 kHz and sampled at 50 kHz.
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tions, and then calculating statistics from the resultant shifts,
was 37.0 þ 2.2 mV. Likewise, the average value of the steep-
ness constant (K) among cells was not changed by Q1-Z
(5.5 þ 0.6 mV versus 6.4 þ 1.1 mV) but the average increase
in K, calculated as above by comparing each cell with itself
before and after application of Q1-Z, was 0.93 þ 0.61 mV.
These shifts in the voltage dependence of inactivation, while
statistically signi¢cant, do not explain the observed inhibition
of INa. To measure inhibition of INa, a pre-pulse to 3100 mV
for 200 ms was applied to remove fast inactivation. The net
e¡ect of the negative shift in V0:5 and the increase in K would
be a slight increase in steady-state inactivation at 3100 mV.
Given the numerical values presented above however, one can
calculate that this will result in an apparent inhibition of only
V1%, whereas we observed 25% inhibition at this concentra-
tion of Q1-Z.
In order to determine what e¡ect Q-zeathionins have on K
channels, whole-cell currents were measured before and dur-
ing application of 400 WM Q1-Z, a concentration that elimi-
nated INa (Fig. 5). Part A shows the currents elicited during
voltage steps from 370 and +60 mV in intervals of 10 mV.
Application of 400 WM Q1-Z eliminated the sodium current. In
Part B, the I^V relationship of the peak inward current (i.e.
INa) and the steady-state current (i.e. IK) is shown. INa was
eliminated whereas IK appeared unchanged.
The W-conotoxins, one of many neurotoxins that target so-
dium channels [20], compete for the guanidinium toxins tetro-
dotoxin and saxitoxin binding site and prevent sodium per-
meation [21^23]. In addition to functional similarity, Q-
thionins and W-conotoxins share structural similarities which
suggest a common mechanism of action.
Many studies have been carried out to identify which resi-
dues of W-conotoxins are involved in the binding and blocking
activity [24^27]. One important characteristic required for
blockage of Na conductance is the presence of a positively
charged region on the neurotoxin since there is a negative
charge at the mouth of the pore and the resultant electrostatic
forces contribute to the attachment of the toxin to its binding
site on the channel [28]. This basic pro¢le is also found in the
Q-thionin family, whose members are characterized by their
relative abundance of Arg and Lys residues in their sequences
(Fig. 6), producing a net positive charge (pIs 8) on these
molecules [2^7].
Several derivatives of W-conotoxin GIIIA were synthesized
and functional studies have demonstrated that toxin residue
Arg-13 is the most important residue for its blocking activity
[24^27]. Arg-13 interacts strongly with Glu-758 and less
strongly with Glu-403 on the channel [27] in a way similar
to that of the guanidinium moieties of TTX and STX [29].
This critical Arg residue is conserved among the Q-thionin
members and it is located in a cluster of positively charged
amino acids on the C-terminal region of these molecules [7].
An identical distribution of basic residues is also present on W-
conotoxin molecules, as illustrated in Fig. 6.
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Fig. 3. Voltage dependence of INa in the presence of 50 WM Q1-Z.
Cells were held at 380 mV then stepped to 3100 mV for 200 ms to
remove fast inactivation followed by steps to voltages ranging from
360 mV to +70 mV in 10 mV increments. The peak current during
control perfusion (a) and during perfusion with 50 WM Q1-Z (b)
was plotted versus voltage. The smooth line represents the best ¢t
of the equation I = gU(V3Vrev)/[1+exp(3(V3V0:5)/K)]. Best ¢t pa-
rameters were as follows. Control: g = 22.5 nS, Vrev = + 60 mV,
V0:5 =317 mV, K = 5.6 mV; Q1-Z: g = 17.1 nS, Vrev = + 59 mV,
V0:5 =316 mV, K = 6.7 mV. Shown is one typical experiment of
three from di¡erent cells (see text for statistics). Solutions: physio-
logic (see Section 2). Filtered at 2 kHz, sampled at 10 kHz.
Fig. 4. Voltage dependence of steady-state inactivation of INa in the
presence of 50 WM Q1-Z. Cells were held at 380 mV, then stepped
for 200 ms to pre-pulse voltages ranging from 390 mV to 325 mV
in 5 mV increments, followed by a test pulse to 0 mV for 50 ms
during which currents were recorded. The normalized peak current
measured during control perfusion (a) and during perfusion with 50
WM Q1-Z (b) was plotted versus pre-pulse voltage. The smooth line
represents the best ¢t of the equation I = Imax/[1 + exp(3(V3V0:5)/
K)]. Best ¢t parameters were as follows. Control: V0:5 =357 mV,
K = 5.8 mV; Q1-Z: V0:5 =363 mV, K = 7.1 mV. Shown is one typical
experiment of four from di¡erent cells. Statistics are discussed in
the text. Solutions: physiologic (see Section 2). Filtered at 2 kHz,
sampled at 10 kHz.
Fig. 2. Dose response of inhibition of INa by (b) Q1-Z or (E) Q2-Z.
Na currents were measured during pulses to 0 mV before and dur-
ing perfusion with Q-zeathionin. Inhibition was calculated as
100%U(IC3IZ)/IC, where IC and IZ are the currents measured in
control solution and in the presence of Q-zeathionin, respectively.
Sample size (number of cells tested) varied as follows: 50 WM Q1-Z,
n = 4; 50 WM Q2-Z, n = 3; 400 WM Q1-Z, n = 4; other concentrations,
n = 1. Where shown, error bars are 95% con¢dence limits. Smooth
curve is the best ¢t of the equation I = C/(C+IC50), using only the
data for Q1-Z.
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The three-dimensional structures of W-conotoxins GIIIA
[30] and GIIIB [31] have been determined and these peptides
adopt a common global fold consisting of a compact structure
stabilized by three disul¢de bridges, two of which connect the
helix and the small L-hairpin, forming a structural core with
similarities to the cysteine-stabilized KL (CSKL) motif. The
CSKL motif could be represented as a LKLL (or KLL) type
sequence and it is shared by several proteins and peptides
with di¡erent toxic properties, including Q-thionins [11]. The
same characteristics are found in GIIIB, but the strand and
the helix are connected in the opposite direction [31].
Recently, the 3D structure of a small antimicrobial peptide
isolated from seeds of Impatiens balsamina has been reported,
and this structure was compared with those of K-conotoxins,
paralytic peptides isolated from Conus venom. Although their
disul¢de connectivities are similar, their folds are not. No
similar active sites were found between these peptides [32].
Thus to our knowledge, the present report is the ¢rst example
of structural similarities between conotoxins and plant defen-
sins.
The potencies of Q1-Z and Q2-Z are similar to those of
toxins from plants that a¡ect Na channels, such as aconitine
and veratridine and to batrachotoxin from frog skin, which
are e¡ective in the 1^100 WM range [33]. However, these lipid-
soluble Na channel toxins open the channel and depolarize
the membrane, a mechanism di¡erent from the conductance-
blocking activity we propose for Q-zeathionins. It is thus more
appropriate to compare Q-zeathionins with scorpion, spider
and Conus peptide toxins (e¡ective at concentrations 6 1 WM
[34,35]). Di¡erences between the species may account for
some of the di¡erence in potencies between Q-zeathionins
and the other Na channel peptide toxins. Animals that
hunt require potent toxins to immobilize their prey; plants
need only impart a chronic inhibition of some critical function
(e.g. sodium channels) in order to gain an evolutionary ad-
vantage. Alternatively, since the overall structure of ion chan-
nels is conserved among eukaryotes [33], the Q-zeathionins
may prove to be more potent inhibitors of channels from
insects, which may be their native target.
In summary, we have shown that Q1-Z and Q2-Z reversibly
block the voltage-gated sodium channel. We observed no ef-
fects on the voltage dependence of inactivation or steady-state
inactivation that could explain this inhibition, and thus sug-
gest Q-zeathionins block the conductance of the sodium chan-
nel (i.e. either reduce the open channel conductance or de-
crease the number of channels that open during a voltage
step). To our knowledge, this is the ¢rst example of a plant
protein that blocks the sodium channel in animal cells.
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Fig. 5. E¡ect of 400 WM Q1-Z on INa and IK. Cells were held at
380 mV, stepped to 3100 mV for 20 ms then stepped to test vol-
tages ranging from 380 to +50 mV in 10 mV increments. A: Cur-
rents and voltage protocol. B: I^V relationship of INa (the peak in-
ward current) and IK (the steady-state outward current measured
80 ms after the onset of the test pulse). Solutions: physiologic (see
Section 2). Filtered at 1 kHz, sampled at 2.5 kHz.
Fig. 6. Sequence alignment between W-conotoxins and Q-thionins. Gaps are included to maximize sequence similarity. Q1-P and Q2-P, Q1-puro-
thionin and Q2-purothionin [2] ; Q1-H, Q1-hordothionin [3]; SIK1 and SIK3, K-amylase sorghum inhibitor 1 and K-amylase sorghum inhibitor 3
[4]; Q1-Z and Q2-Z, Q1-zeathionin and Q2-zeathionin [7]; GIIIA, GIIIB and GIIIC, W-conotoxin GIIIA, W-conotoxin GIIIB and W-conotoxin
GIIIC [14]. P = hydroxyproline and Arg-13 in bold.
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